Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
melatonin (1 trial)
cyp-001 (1 trial)
allogeneic cord blood (1 trial)
Acute Lung Injury (Phase 2)
Cerebral Palsy (Phase 1)
Respiratory Distress Syndrome (Phase 2)
Respiratory Distress Syndrome, Newborn (Phase 2)
Trials (3 total)
Trial APIs (3 total)